Navigation Links
Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
Date:2/4/2008

http://www.akelapharma.com Toronto Stock Exchange Symbol: AKL

MONTREAL, Feb. 4 /PRNewswire-FirstCall/ - Akela Pharma Inc. (TSX: "AKL"), a drug development company focused on developing therapies for the inhalation and pain markets, today announced that it has received notice from the FDA that, due to GLP deviations the 6-month inhalation toxicology studies were deemed invalid. No toxicological reasons were cited. We are currently evaluating several alternative remedies and are confident that the submission for regulatory approval will not be delayed by more than 6 months.

Conference call information:

Akela will host a conference call at 9:00 am, on Monday February 4, 2008. Interested parties may also access the conference call by webcast at http://www.akelapharma.com.

The telephone numbers to access the conference call are 1-800-732-9303 or 416-644-3415. A replay of the call will be available until February 11, 2008. The telephone numbers to access the replay are 416-640-1917 and 1-877-289-8525 with code number 21262067#.

About Akela Pharma Inc.:

Akela Pharma is an integrated drug development company focused on developing therapies for the growing multi-billion dollar inhalation and pain markets. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, growth hormone deficiencies and controlled substance abuse deterrent formulations.

Akela's common shares trade on The Toronto Stock Exchange ("TSX") under the symbol "AKL" with 11.7 million shares outstanding.

This news release contains certain forward-looking statements that reflect the current views and/or expectations of Akela Pharma Inc. with respect to its performanc
'/>"/>

SOURCE Akela Pharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Akela Pharma provides corporate update
2. Akela Pharma announces final positive results from its growth hormone releasing hormone (GHRH) Phase II trial
3. Akela Pharma reports results for third quarter of fiscal 2007
4. AKELA Pharma Inc. announces U.S. public offering and proposed listing
5. Akela Pharma Inc. Completes Share Consolidation
6. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
7. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
8. Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
9. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
10. West Hollywood: AHF Hosts Grand Opening of HIV/AIDS Pharmacy that Benefits AIDS Patients Worldwide
11. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 Consuming too ... How to know? , Read the labels! , Learn ... determine how it relates to health during a "Healthy ... Aug. 1 at Humility House, 755 Ohltown Road, Austintown. ... lead an informational discussion and answer questions. , ...
(Date:7/25/2014)... The Gerontological Society of America (GSA) ... field of aging has chosen Heather M. ... California, Davis, as the 2014 recipient of the ... distinguished honor, presented by GSA,s Health Sciences Section, ... in recognition of outstanding and sustained contribution to ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 As reported by ... OD Deaths Increase (7/20), Michigan has seen a nearly 500-person ... years. While the count was 271 between 1999 and 2002, ... DEA Agents believe that, like other states, drug users in ... drug via prescription pills. He compared the price of both ...
(Date:7/25/2014)... 25, 2014 As reported by People Magazine ... After Jersey Shore and Getting Sober (7/15), one of ... Shore, has spoken out to the public about his personal ... show, The Situation admits that moving on with his life ... drugs, and other drugs in 2012 and even spent some ...
(Date:7/25/2014)... The Little Gym of Houston will attend ... 27 at Discovery Green in downtown Houston. The ... Friendswood, Spring, The Woodlands, Sugarland-Missouri City, Kingwood, Bellaire and ... thrilled to be attending and performing at the Family ... the Sugarland-Missouri City location. “We believe in the message ...
Breaking Medicine News(10 mins):Health News:Learn to Decipher Food Labels at Humility House 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2
... Alzheimer,s disease is not the only type of dementia. ... disease dementia. In both forms, the diagnosis is of vital ... for Alzheimer,s dementia, as Brit Mollenhauer and co-authors explain in ... (Dtsch Arztebl Int 2010; 107[39]: 684-91). In more ...
... Oct. 14 (HealthDay News) -- Emergency dispatchers should advise ... rather than the standard protocol of chest compressions and ... findings echo the results of other recent reports that ... compressions may be the key to successful CPR, according ...
... ChoiceBatter,s transformation from a federal laboratory bench technology ... be discussed here today by U.S. Department of Agriculture (USDA) ... the National Association of Seed and Venture Funds (NASVF). ... batters marketed by CrispTek, LLC, of Columbia, Md., is based ...
... continue to indicate that higher intake of alcohol during ... very severe developmental or other problems in the child. ... effects of occasional or light drinking by the mother ... education, and other lifestyle factors of the mother may ...
... the Oct. 15 issue of the Journal of Clinical ... much higher prevalence and risk of restless legs syndrome than ... improve sleep and quality of life in people with fibromyalgia. ... was about 10 times higher in the fibromyalgia group (33 ...
... 14, 2010 David G. Daniel (FACHE, FAAMA, ... Surgical & Diagnostic Center (LSDC) in Lakeland, Fla., ... annual Healthcare Administrator Award, presented by the Association ... Mr. Daniel received the award at a Washington ...
Cached Medicine News:Health News:More Evidence That Compression-Only CPR Works Best 2Health News:Small business success spotlighted by USDA at conference 2Health News:2 studies present new data on effects of alcohol during pregnancy 2Health News:Study finds a high rate of restless legs syndrome in adults with fibromyalgia 2Health News:APIC honors Florida ambulatory surgery center executive 2
(Date:7/25/2014)... -- Research and Markets has announced the ... 2014-2018" report to their offering. ... Device An ophthalmic diagnostic device is ... deficiency in the human visual pathway. Ophthalmic devices are ... cataracts, glaucoma, retinal disorders, conjunctivitis, and dry eyes. ...
(Date:7/25/2014)... , July 25, 2014  AMETEK, Inc. (NYSE: ... Kurtis L. Goos as Vice President and General ... and Packaging (EMIP) Division. "I am pleased ... management and business development experience, especially in the medical ... contributions to the continued growth and success of our ...
(Date:7/25/2014)... 2014 Leading events organizer UBM Live ... the seventh year to São Paulo, Brazil ... 2014. The event will co-locate with Food Ingredients South America ... meeting point for the pharmaceutical industry.      (Logo: ... pharmaceutical sales are now exploring the South America ...
Breaking Medicine Technology:Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4
... , Breakthrough findings unveiled at the American Society of ... WASHINGTON, June 8 The American Society of Echocardiography ... to present their most-recent findings at its 20th Annual ... Center in Washington, DC. This year, NBA basketball ...
... at the 14th Congress of the European Hematology Association ... Disease , , BERLIN, June 8 Micromet, ... developing novel, proprietary antibodies for the treatment of cancer, ... ALL Study Group (GMALL) presented phase 2 clinical data ...
Cached Medicine Technology:New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients 2New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients 3New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients 4Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 2Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 3Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4Micromet's Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 5
For use with WarmTouch® Warming Blankets for the prevention or treatment of hypothermia...
The Synoptiscope(L-2510HB) has a wide variety of functions including binocular function diagnosis and treatment....
Since 1964, in its plants of Sesto Fiorentino, Sbisà produces a wide and qualified range of instruments for ophthalmology and optometry....
Inquire...
Medicine Products: